Evidence map›Paper›PMID 39976427›Full record

ArticleAntimicrobial agents and chemotherapy2025

Deciphering meropenem persistence in

Arsalan Hussain, Timsy Bhando, Ananth Casius, Rinki Gupta, Ranjana Pathania

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Arsalan Hussain *Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.ORCID 0009-0000-0944-1337
Timsy Bhando *Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.
Ananth Casius *Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.
Rinki GuptaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.
Ranjana PathaniaDepartment of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee, India.ORCID 0000-0002-7965-8176

Funding

Department of Biotechnology, Ministry of Science and Technology, India (DBT) DBT/2018/IIT-R/1144Department of Biotechnology, Ministry of Science and Technology, India (DBT) PG SCHOLARSHIPMinistry of Human Resource and Development, Government of India
6 · The paper itself

Abstract

Decades of antibiotic misuse have accelerated the emergence of multi- and extensively drug-resistant bacteria. Bacterial pathogens employ several strategies such as antibiotic resistance, tolerance, and biofilm formation in response to extreme environments and antibiotic stress. Another crucial survival mechanism involves the stochastic generation of bacterial subpopulations known as persisters, which can endure high concentrations of antibiotics. Upon removal of antibiotic stress, these subpopulations revert back to their original phenotype which links them to the relapse and recalcitrance of chronic infections, a significant problem in clinical settings. Persistent infections are particularly notable in

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsMeropenemThymolAcinetobacter InfectionsBiofilmsCarbapenemsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsAnti-Bacterial AgentsCarbapenemsMeropenemThymolantibiotic resistanceanti-persistermulti-drug tolerancespontaneous persistersthymol

Identifiers

PMID39976427
PMCPMC11963602

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.